SSA
IRON icon

Schonfeld Strategic Advisors’s Disc Medicine IRON Stock Holding History

Schonfeld Strategic Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,552
Closed -$375K – 2270
2025
Q1 		$375K Buy
7,552
+2,652
+54% +$147K ﹤0.01% 1703
2024
Q4 		$311K Sell
4,900
-381
-7% -$22K ﹤0.01% 1597
2024
Q3 		$260K Sell
5,281
-1,643
-24% -$77.1K ﹤0.01% 1719
2024
Q2 		$312K Sell
6,924
-41,655
-86% -$1.42M ﹤0.01% 1672
2024
Q1 		$3.02M Buy
48,579
+26,233
+117% +$1.7M 0.02% 838
2023
Q4 		$1.29M Buy
22,346
+9,646
+76% +$494K 0.01% 947
2023
Q3 		$597K Buy
12,700
+5,500
+76% +$275K ﹤0.01% 1162
2023
Q2 		$320K Buy
+7,200
New +$255K ﹤0.01% 1377

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Schonfeld Strategic Advisors's IRON Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of Disc Medicine (IRON) in Q2 2025, closing a stake of 7,552 shares — an estimated $375K sold.

Schonfeld Strategic Advisors first reported a position in IRON in Q2 2023 and held it in 8 quarters. The position peaked at $3.02M in Q1 2024. 151 funds tracked by Wall St. Rank hold IRON as of Q2 2025.

  • Schonfeld Strategic Advisors reported no remaining Disc Medicine position as of Q2 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 7,552 Disc Medicine shares in Q2 2025, an estimated $375K.
  • Schonfeld Strategic Advisors first reported a position in Disc Medicine in Q2 2023 and held it in 8 quarters.
  • Schonfeld Strategic Advisors's Disc Medicine position peaked at $3.02M in Q1 2024.
  • 151 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.